⌘K

Login Start Free

Home/Filings/4/0001104659-25-077777

4//SEC Filing

POSTE GEORGE 4

Accession 0001104659-25-077777

CIK 0002019410other

View on SEC.gov Company Profile

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 8:07 PM ET

Size

10.6 KB

Accession

0001104659-25-077777

Insider Transaction Report

Form 4

Period: 2025-08-11

Caris Life Sciences, Inc.CAI

Director

Transactions

Exercise/Conversion
Common Stock
2025-08-11$2.44/sh+125,000$305,000→ 359,754 total
Tax Payment
Common Stock
2025-08-11$29.75/sh−48,022$1,428,655→ 311,732 total
Tax Payment
Common Stock
2025-08-11$29.75/sh−91,495$2,721,976→ 220,237 total
Exercise/Conversion
Stock Option
2025-08-11+125,000→ 0 total
Exercise: $2.44Exp: 2025-09-15→ Common Stock (125,000 underlying)

Holdings

Common Stock
(indirect: By Trust)
307,594

Footnotes (1)

[F1]The stock option is fully vested and exercisable.

Documents

1 file

4
tm2523446-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Caris Life Sciences, Inc.

CIK 0002019410

Entity typeother

Related Parties

1

filerCIK 0001180770

Filing Metadata

Form type: 4
Filed: Aug 12, 8:00 PM ET
Accepted: Aug 13, 8:07 PM ET
Size: 10.6 KB

View on SEC.gov